Jill Carroll bought $5.0M of Avalyn Pharma (AVLN)

Executed May 1, disclosed May 1, the same day.

Value, as filed

$5.0M

277,778 sh × $18.00

Executed

May 1

the trade date, as filed

Disclosed

May 1

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

-4.8%

-4.8% from execution

Over the 21 trading sessions from the disclosed entry session (May 1), the stock returned -4.8% (delay-adjusted); from the execution session (May 1), -4.8%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

JC Jill Carroll Director profile →

Jill Carroll (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in AVLN. Across 1 priced purchase filing, the average 21-session return was -4.8% from execution and -4.8% from disclosure (delay-adjusted; derived). The largest single filing was $5.0M of AVLN (277,778 sh × $18.00, as filed), executed May 1.

The name

AVLN AVLN AVLN · 3 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→